Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study shows no link between race and mortality in clear cell RCC

Publish date:: December 17, 2020

Key clinical point: There was no association between race and 5-year cause-specific survival in patients with clear cell renal cell carcinoma.

Major finding: In an adjusted analysis, the hazard ratios for death were 0.96 for Black patients, 1.01 for American Indian/Alaskan patients, and 0.99 for Asian/Pacific Islander patients, with White patients as the comparator.

Study details: A retrospective analysis of 8,421 subjects with clear cell renal cell carcinoma in the multistate Surveillance Epidemiology, and End Results database.

Disclosures: The researchers did not disclose funding or conflicts of interest.

Citation:

Jivanji D et al. Urology. 2020. doi: 10.1016/j.urology.2020.10.055.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Diversity in Medicine

Study shows no link between race and mortality in clear cell RCC,

Black patients with ES-SCLC get less chemo but have better survival,

Family planning issues loom large for female radiation oncologists,